A Scientific Crisis That Starts in the Market, Not the Lab

Proteintech CEO, Dr. Jason Li evaluates the 'Reproducibility crisis' and it's effect on the antibody market


The Reproducibility Crisis: Why should antibody care?

Proteintech Group CEO, Dr. Jason Li, has always believed in an antibody market built on transparency and supplier accountability. The emergence of the ‘Reproducibility Crisis’ in the life science community has highlighted the need to address issues such as the re-branding of antibodies. Follow the link below to read Dr. Li’s most recent article that discusses how market forces has led to a lack of transparency and ultimately, faulty products in the antibody market.  

Article published in Scientific American, September 2016.

A Scientific Crisis That Starts in the Market, Not the Lab

Article by Dr Jason Li for  Scientific American's Guest Blog

Only 50 percent of the antibodies produced commercially for biomedical research actually do what they're supposed to... 

Read the full article...


Original Manufacturer: Original Products

Part of Proteintech’s early vision was to make all its own products, to the highest standards possible and to take complete responsibility for the quality of each product.

  • Proteintech make every single antibody in its 12,000+ catalog.
  • All products are exclusively available to buy through Proteintech and its approved distributors.
  • Each Proteintech antibody is unique and cannot be bought under a different label.
Company News

Posted:
15 September, 2016

Share:


Back
to top